BASAL CELL CARCINOMA (BCC)
Clinical trials for BASAL CELL CARCINOMA (BCC) explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA (BCC) trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA (BCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy trial targets Tough-to-Treat skin cancer
Disease control Recruiting nowThis study is testing whether the immunotherapy drug cemiplimab can help control advanced basal cell carcinoma when used as the first treatment. The trial will enroll about 34 adults with locally advanced skin cancer that cannot be treated with surgery or radiation. Participants …
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC
-
Light and pill combo targets skin cancer without surgery
Disease control Recruiting nowThis early-stage study is testing a combination treatment for people with multiple basal cell skin cancers (BCCs). It combines a blue-light therapy applied to the skin with an oral drug called sonidegib. The goal is to see if this approach is safe and effective for patients who a…
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE1 • Sponsor: Nathalie Zeitouni • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC